Augmentin and Pyogenic liver abscess - a phase IV clinical study of FDA data

Summary:

Pyogenic liver abscess is reported as a side effect among people who take Augmentin (amoxicillin; clavulanate potassium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Creon, and have Pancreatic carcinoma metastatic.

The phase IV clinical study analyzes which people have Pyogenic liver abscess when taking Augmentin. It is created by eHealthMe based on reports of 41,293 people who have side effects when taking Augmentin from the FDA, and is updated regularly.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.

What is Pyogenic liver abscess?

Pyogenic liver abscess (liver abscess caused by bacteria) is found to be associated with 404 drugs and 968 conditions by eHealthMe. Check the latest studies of Pyogenic liver abscess.

On Jul, 10, 2026

41,293 people reported to have side effects when taking Augmentin.
Among them, 11 people (0.03%) have Pyogenic liver abscess.

Could Augmentin cause Pyogenic liver abscess?

Among these 11 people:

How long have people been on Augmentin when they have Pyogenic liver abscess? *

What is the gender of people who have Pyogenic liver abscess when taking Augmentin? *

female: 90 %
male: 10 %

What is the age of people who have Pyogenic liver abscess when taking Augmentin? *

What are other drugs people take besides Augmentin? *

What are other side effects people have besides Pyogenic liver abscess? *

Anaemia (lack of blood): 5 people, 45.45%
Weakness: 3 people, 27.27%
Abdominal Pain: 3 people, 27.27%
Diarrhea: 3 people, 27.27%
Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 27.27%
Appendicitis (inflammation of the appendix): 2 people, 18.18%
Constipation: 2 people, 18.18%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 2 people, 18.18%
Back Pain: 2 people, 18.18%
Ascites (accumulation of fluid in the abdominal cavity): 2 people, 18.18%

What are the existing conditions these people have? *

Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 2 people, 18.18%
Type 2 Diabetes: 1 person, 9.09%
Hypokalemia (low potassium): 1 person, 9.09%
Chest Pain: 1 person, 9.09%
Colorectal Cancer Metastatic (cancer of colon and rectal spreads to other parts): 1 person, 9.09%
Constipation: 1 person, 9.09%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 9.09%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 9.09%
Dry Eyes (lack of adequate tears): 1 person, 9.09%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin and have Pyogenic liver abscess?

- Check whether Pyogenic liver abscess is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Augmentin:

Augmentin (42,620 reports)

Pyogenic liver abscess treatments and more:

Pyogenic liver abscess (4,754 reports)

How severe was Pyogenic liver abscess and when was it recovered:

Pyogenic liver abscess in Augmentin

Expand to all the drugs that have ingredients of amoxicillin; clavulanate potassium:

Pyogenic liver abscess and drugs with ingredients of amoxicillin; clavulanate potassium (17 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pyogenic liver abscess:

Pyogenic liver abscess (404 drugs)

Browse all the conditions that are associated with Pyogenic liver abscess:

Pyogenic liver abscess (968 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium (the active ingredients of Augmentin) and Augmentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.